233 related articles for article (PubMed ID: 9233765)
1. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
Lutz W; Schwab M
Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
[TBL] [Abstract][Full Text] [Related]
2. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
[TBL] [Abstract][Full Text] [Related]
3. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells.
Wada RK; Seeger RC; Reynolds CP; Alloggiamento T; Yamashiro JM; Ruland C; Black AC; Rosenblatt JD
Oncogene; 1992 Apr; 7(4):711-7. PubMed ID: 1565467
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
6. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Chambéry D; Mohseni-Zadeh S; de Gallé B; Babajko S
Cancer Res; 1999 Jun; 59(12):2898-902. PubMed ID: 10383152
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
8. Expression of the TAF4b gene is induced by MYC through a non-canonical, but not canonical, E-box which contributes to its specific response to MYC.
Teye K; Okamoto K; Tanaka Y; Umata T; Ohnuma M; Moroi M; Kimura H; Tsuneoka M
Int J Oncol; 2008 Dec; 33(6):1271-80. PubMed ID: 19020761
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer.
Woodruff KA; Rosenblatt JD; Moore TB; Medzoyan RH; Pai DS; Noland JL; Yamashiro JM; Wada RK
Oncogene; 1995 Apr; 10(7):1335-41. PubMed ID: 7731684
[TBL] [Abstract][Full Text] [Related]
10. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
Ben-Yosef T; Yanuka O; Benvenisty N
Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
[TBL] [Abstract][Full Text] [Related]
11. A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma.
Watt F; Watanabe R; Yang W; Agren N; Arvidsson Y; Funa K
Cancer Gene Ther; 2007 Mar; 14(3):287-96. PubMed ID: 17124508
[TBL] [Abstract][Full Text] [Related]
12. Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2.
Kim MK; Carroll WL
Cancer; 2004 Nov; 101(9):2106-15. PubMed ID: 15382088
[TBL] [Abstract][Full Text] [Related]
13. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
14. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.
Grandinetti KB; Spengler BA; Biedler JL; Ross RA
Oncogene; 2006 Feb; 25(5):706-12. PubMed ID: 16278682
[TBL] [Abstract][Full Text] [Related]
15. Sequence of the 5'-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells.
Van Seuningen I; Perrais M; Pigny P; Porchet N; Aubert JP
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):675-86. PubMed ID: 10840001
[TBL] [Abstract][Full Text] [Related]
16. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
Batsché E; Crémisi C
Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
[TBL] [Abstract][Full Text] [Related]
17. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
18. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
Luo Q; Li J; Cenkci B; Kretzner L
Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
[TBL] [Abstract][Full Text] [Related]
19. Fli-1b is generated by usage of differential splicing and alternative promoter.
Dhulipala PD; Lee L; Rao VN; Reddy ES
Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
[TBL] [Abstract][Full Text] [Related]
20. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
Barbeau B; Barat C; Bergeron D; Rassart E
Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]